tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Anixa Biosciences Inc

ANIX
Add to Watchlist
3.860USD
+0.110+2.93%
Close 07-23 16:00（ET）Quotes delayed by 15 min
130.94MMarket Cap
LossP/E TTM

Anixa Biosciences Inc

3.860
+0.110+2.93%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

ANIX Financials

See Anixa Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Anixa Biosciences Inc Earnings Date

Latest Release
Jun 10, 2026
EPS / Forecast
-0.07/-0.09
Revenue / Forecast
--/0.00
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.34
14.45%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
13.55%-0.07
21.96%-0.08
8.67%-0.08
31.99%-0.07
11.92%-0.09
4.46%-0.10
-3.57%-0.09
-26.10%-0.10
-32.97%-0.10
-37.85%-0.10
23.44%-0.09
---0.08
---0.07
---0.08
---0.11
----
----
----
----
----
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--210.00K
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
Net Profit
9.82%-2.52M
19.44%-2.56M
6.52%-2.69M
31.10%-2.26M
11.12%-2.79M
2.18%-3.18M
-7.17%-2.88M
-30.51%-3.28M
-37.19%-3.14M
-40.18%-3.25M
22.61%-2.69M
8.56%-2.51M
35.44%-2.29M
39.36%-2.32M
13.39%-3.48M
36.64%-2.75M
-47.74%-3.54M
-73.39%-3.83M
-80.45%-4.01M
-69.19%-4.33M
Net Margin
----
----
----
----
----
----
----
----
----
----
----
----
---1098.57%
----
----
----
----
----
----
----
Gross Margin
----
----
----
----
----
----
----
----
----
----
----
----
--100.00%
----
----
----
----
----
----
----
Income Statement
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--210.00K
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
Operating profit
11.85%-2.65M
19.79%-2.72M
9.07%-2.88M
32.18%-2.44M
13.38%-3.00M
6.18%-3.39M
-3.67%-3.16M
-26.30%-3.59M
-44.52%-3.47M
-41.20%-3.61M
15.46%-3.05M
-1.68%-2.84M
33.16%-2.40M
34.12%-2.56M
11.48%-3.61M
36.26%-2.80M
-47.25%-3.59M
-109.94%-3.88M
-81.83%-4.08M
-80.14%-4.39M
Net Profit
9.82%-2.52M
19.44%-2.56M
6.52%-2.69M
31.10%-2.26M
11.12%-2.79M
2.18%-3.18M
-7.17%-2.88M
-30.51%-3.28M
-37.19%-3.14M
-40.18%-3.25M
22.61%-2.69M
8.56%-2.51M
35.44%-2.29M
39.36%-2.32M
13.39%-3.48M
36.64%-2.75M
-47.74%-3.54M
-73.39%-3.83M
-80.45%-4.01M
-69.19%-4.33M
Balance Sheet
Current assets
-12.37%14.69M
-19.46%15.05M
-25.63%15.89M
-23.03%17.45M
-30.76%16.77M
-25.91%18.69M
-15.75%21.36M
-14.13%22.67M
-11.66%24.21M
-10.27%25.22M
-16.04%25.36M
-18.37%26.40M
-15.82%27.41M
-19.69%28.11M
-16.12%30.20M
-12.72%32.34M
-15.36%32.56M
140.27%34.99M
284.30%36.00M
299.97%37.05M
Total current liabilities
-20.46%1.50M
-38.17%1.24M
-21.32%1.97M
3.09%2.07M
12.25%1.89M
20.42%2.00M
23.27%2.50M
7.92%2.00M
9.37%1.68M
34.74%1.66M
-0.44%2.03M
26.41%1.86M
29.27%1.54M
-31.06%1.23M
60.33%2.04M
21.60%1.47M
-17.59%1.19M
17.14%1.79M
6.89%1.27M
-0.43%1.21M
Total assets
-12.44%14.87M
-19.43%15.23M
-25.52%16.08M
-22.95%17.65M
-30.29%16.98M
-25.48%18.91M
-15.40%21.59M
-13.81%22.91M
-11.75%24.36M
-10.37%25.37M
-16.08%25.52M
-18.38%26.58M
-15.85%27.60M
-19.67%28.31M
-16.12%30.41M
-12.14%32.56M
-14.81%32.80M
141.28%35.24M
283.56%36.26M
295.89%37.06M
Total liabilities
-20.76%1.64M
-36.75%1.39M
-21.20%2.13M
1.04%2.24M
16.74%2.07M
24.04%2.19M
25.66%2.70M
11.24%2.22M
5.22%1.77M
26.83%1.77M
-2.76%2.15M
20.35%1.99M
21.21%1.69M
-30.16%1.39M
48.40%2.21M
37.08%1.66M
-3.59%1.39M
30.84%2.00M
25.41%1.49M
-1.29%1.21M
Total equity
-11.28%13.22M
-17.15%13.85M
-26.14%13.95M
-25.52%15.41M
-33.99%14.91M
-29.19%16.71M
-19.18%18.89M
-15.84%20.69M
-12.86%22.58M
-12.29%23.60M
-17.12%23.37M
-20.45%24.59M
-17.49%25.91M
-19.04%26.91M
-18.89%28.20M
-13.80%30.91M
-15.24%31.41M
154.16%33.24M
320.68%34.77M
340.58%35.85M
Cash Flow Statement
Net operating income
-15.83%-1.74M
10.12%-2.61M
-35.38%-1.25M
42.83%-1.51M
-3.23%-1.50M
-25.77%-2.90M
52.92%-927.00K
-82.91%-2.64M
-80.42%-1.46M
-16.15%-2.31M
-23.60%-1.97M
-3.51%-1.45M
65.00%-807.00K
-66.08%-1.99M
-52.56%-1.59M
5.72%-1.40M
-85.74%-2.31M
-2.27%-1.20M
26.16%-1.04M
-14.70%-1.48M
Net investment
-81.98%422.00K
-54.57%1.23M
-24.57%654.00K
-130.58%-833.00K
321.22%2.34M
1995.35%2.70M
246.21%867.00K
377.96%2.72M
116.14%556.00K
122.05%129.00K
94.02%-593.00K
66.33%-980.00K
-1477.60%-3.44M
-131.62%-585.00K
-453.34%-9.92M
-391.24%-2.91M
102.98%250.00K
173.89%1.85M
461.33%2.81M
292.21%999.52K
Net financing
6838.89%1.25M
10011.76%1.69M
230.19%350.00K
1194.63%1.93M
-97.99%18.00K
-100.75%-17.00K
-62.01%106.00K
4866.67%149.00K
1007.41%897.00K
75333.33%2.26M
172.66%279.00K
-99.64%3.00K
1057.14%81.00K
--3.00K
-367.37%-384.00K
--829.00K
-99.97%7.00K
-100.00%0.00
-89.76%143.62K
-100.00%0.00

FAQs

What are the current assets of Anixa Biosciences Inc?

According to Anixa Biosciences Inc's FY2025 earnings report, its current assets were 15.89M, with a year-on-year change of -25.63.

What are the total assets of Anixa Biosciences Inc?

According to Anixa Biosciences Inc's FY2025 earnings report, its total assets of Anixa Biosciences Inc were 16.08M, with a year-on-year change of -25.52.

What are the total liabilities of Anixa Biosciences Inc?

According to Anixa Biosciences Inc's FY2025 earnings report, its total liabilities of Anixa Biosciences Inc were 2.13M, with a year-on-year change of -21.20.

What is the total equity of Anixa Biosciences Inc?

According to Anixa Biosciences Inc's FY2025 earnings report, its total equity of Anixa Biosciences Inc was 13.95M, with a year-on-year change of -26.14.

What is the net operating income of Anixa Biosciences Inc?

According to Anixa Biosciences Inc's FY2025 earnings report, its net operating income of Anixa Biosciences Inc was -11.70M, with a year-on-year change of 15.40.

What is the net investment of Anixa Biosciences Inc?

According to Anixa Biosciences Inc's FY2025 earnings report, its net investment of Anixa Biosciences Inc was 4.87M, with a year-on-year change of 13.80.

What is the net financing of Anixa Biosciences Inc?

According to Anixa Biosciences Inc's FY2025 earnings report, its net financing of Anixa Biosciences Inc was 2.28M, with a year-on-year change of -33.24.

What is the Earnings Per Share (EPS) of Anixa Biosciences Inc?

According to Anixa Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.34, with a year-on-year change of 14.45.

What is the net income of Anixa Biosciences Inc?

According to Anixa Biosciences Inc's FY2025 earnings report, its net income was -10.93M, with a year-on-year change of 12.96.

What is the Return on Equity (ROE) of Anixa Biosciences Inc?

According to Anixa Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -62.16, with a year-on-year change of -9.76.

What is the Return on Assets (ROA) of Anixa Biosciences Inc?

According to Anixa Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -58.55, with a year-on-year change of -8.62.

What is the operating profit of Anixa Biosciences Inc?

According to Anixa Biosciences Inc's FY2025 earnings report, its operating profit was -11.70M, with a year-on-year change of 15.40.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy